Observational studyAmerican journal of hematology2023

The CAR-HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL.

Kai Rejeski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.